Kilitch Drugs India Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 206.787 million compared to INR 105.612 million a year ago. Net income was INR 11.877 million compared to net loss of INR 13.337 million a year ago. Basic earnings per share from continuing operations was INR 0.76 compared to basic loss per share from continuing operations of INR 0.86 a year ago.